biological source
Escherichia coli (O111:B4)
Quality Level
form
lyophilized powder
purified by
phenol extraction
technique(s)
ELISA: suitable, cell based assay: suitable, ligand binding assay: suitable
impurities
≤3.00% protein (Lowry-TCA)
color
off-white to faint yellow
solubility
water: soluble
application(s)
cell analysis
clinical research
life science and biopharma
shipped in
ambient
storage temp.
2-8°C
General description
This product is phenol extracted from Escherichia coli serotype O111:B4. The source strain is from a private collection. This LPS serotype has been used to stimulate B-cells and induce NOS (nitric oxide synthase) in human hepatocytes.
Application
- for the stimulation of macrophages
- for LPS preconditioning in mice
- to induce acute kidney injury in mice
- to induce acute respiratory distress syndrome (ARDS) in mice to study the anti-inflammatory effects of bone marrow mesenchymal stem cell (BMSCs)-derived exosomes
- to induce hyperinflammatory status in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected mice
Biochem/physiol Actions
Preparation Note
Other Notes
Still not finding the right product?
Explore all of our products under Lipopolysaccharides from Escherichia coli O111:B4
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Oral
Storage Class
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Explore the structure, function, and diverse applications of Lipopolysaccharides. Discover their role in bacteria, serological specificity, and research potential.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| L2630-100MG | 04061838446237 |
| L2630-10MG | 04061838446244 |
| L2630-25MG | 04061838446251 |
